Home

David McClung

CIK 1686155 · Chief Financial Officer · last filed 2026-07-07

David McClung is a Chief Financial Officer who has filed 28 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for BCDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is +$53.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $89.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$89.3K

Companies

2

Total Filings

28

Lifetime Open-Market Net

$53.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCDA Chief Financial Officer 114,245 $0.78 $89.3K $49.8K 13 2026-07-07
BioCardia, Inc. (BCDAW) Delisted Chief Financial Officer 135,724 $0.01 $828 $4.1K 15 2023-06-26

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 BCDA Mixed −23,125 -$28.7K EDGAR
2026-07-01 BCDA Grant (A) +60,483 $72.6K EDGAR
2025-12-10 BCDA Mixed +87,615 $120.0K EDGAR
2025-07-02 BCDA Buy (P) +4,819 $10.0K EDGAR
2025-04-25 BCDA Buy (P) +13,123 $25.0K EDGAR
2024-10-16 BCDA Mixed +12,628 $33.5K EDGAR
2024-09-05 BCDA Grant (A) +8,333 $25.0K EDGAR
2023-06-26 BioCardia, Inc. (BCDAW) Delisted Grant (A) +4,280 $10.0K EDGAR
2023-06-02 BioCardia, Inc. (BCDAW) Delisted Tax (F) −20,676 -$36.6K EDGAR
2023-05-22 BioCardia, Inc. (BCDAW) Delisted Grant (A) +61,389 $104.4K EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.